Trial Profile
Phase II Study Exploring Efficacy and Safety of Iodinated Activated Charcoal in COPD.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Charcoal (Primary) ; Iodine
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 11 Feb 2013 Planned end date changed from 1 Oct 2012 to 1 May 2013 as reported by ClinicalTrials.gov.
- 11 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 10 Feb 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.